Hint mode is switched on Switch off
For swift navigation between sections

Tianjin Tianyao Pharmaceutical
LEI 300300RTCD31N1CCMK41

PDF download

Choose all Reset all
Download Cancel
Organization name
Tianjin Tianyao Pharmaceutical Co Ltd
Country name
China
Country of registration
China
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Tianjin Tianyao Pharmaceutical Co Ltd researches, develops, and manufactures corticoid and cardiovascular pharmaceuticals. The Company's products include drug preparation, Chinese medicinal crops, Chinese patent drugs, health care products, and injections. Tianjin Tianyao also provides related technology consulting services.

Awards

News

07/02/2025 Tianjin Tianyao Pharmaceutical Co., Ltd.: Announcement on Obtaining GMP Certification from the Brazilian Health Regulatory Agency
11/01/2024 TIANJIN TIANYAO PHARMACEUTICAL CO., LTD.: Announcement on Resolutions of 1st Special Shareholders' Meeting of 2024
11/01/2024 TIANJIN TIANYAO PHARMACEUTICAL CO., LTD.: Announcement on Subsidiary's Drug Passing Consistency Evaluation of Generic Drug
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    300300RTCD31N1CCMK41
  • SIC
    2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Registration is required to get access.